COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #134 of 230
9/15 Late treatment study
Ashinyo et al., Pan African Medical Journal, 37:1, doi:10.11604/pamj.supp.2020.37.1.25718 (Peer Reviewed)
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study
Source   PDF   Share   Tweet
Retrospective 307 hospital patients in Ghana showing 33% reduction in hospitalization time with HCQ, 29% reduction with HCQ+AZ, and 37% reduction with CQ+AZ.

Ashinyo et al., 9/15/2020, retrospective, Ghana, Africa, peer-reviewed, 16 authors.
hospitalization time, 33.0% lower, relative time 0.67, p = 0.03, treatment 61, control 61.
Details of all 230 studies    Meta analysis
Please submit corrections, updates, or comments.